HUP0004809A3 - Multicyclic erythromycin derivatives - Google Patents

Multicyclic erythromycin derivatives

Info

Publication number
HUP0004809A3
HUP0004809A3 HU0004809A HUP0004809A HUP0004809A3 HU P0004809 A3 HUP0004809 A3 HU P0004809A3 HU 0004809 A HU0004809 A HU 0004809A HU P0004809 A HUP0004809 A HU P0004809A HU P0004809 A3 HUP0004809 A3 HU P0004809A3
Authority
HU
Hungary
Prior art keywords
erythromycin derivatives
multicyclic
multicyclic erythromycin
derivatives
erythromycin
Prior art date
Application number
HU0004809A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of HUP0004809A2 publication Critical patent/HUP0004809A2/hu
Publication of HUP0004809A3 publication Critical patent/HUP0004809A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HU0004809A 1997-05-29 1998-05-22 Multicyclic erythromycin derivatives HUP0004809A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86545397A 1997-05-29 1997-05-29
PCT/US1998/010501 WO1998054197A1 (en) 1997-05-29 1998-05-22 Multicyclic erythromycin derivatives

Publications (2)

Publication Number Publication Date
HUP0004809A2 HUP0004809A2 (hu) 2001-05-28
HUP0004809A3 true HUP0004809A3 (en) 2001-11-28

Family

ID=25345545

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004809A HUP0004809A3 (en) 1997-05-29 1998-05-22 Multicyclic erythromycin derivatives

Country Status (26)

Country Link
EP (1) EP0984975B1 (hu)
JP (1) JP4368950B2 (hu)
KR (1) KR20010013041A (hu)
CN (1) CN1258299A (hu)
AR (1) AR013081A1 (hu)
AT (1) ATE238330T1 (hu)
AU (1) AU7591298A (hu)
BG (1) BG103985A (hu)
BR (1) BR9809489A (hu)
CA (1) CA2290421C (hu)
CO (1) CO4950620A1 (hu)
DE (1) DE69813798T2 (hu)
DK (1) DK0984975T3 (hu)
ES (1) ES2197472T3 (hu)
HU (1) HUP0004809A3 (hu)
IL (1) IL132482A0 (hu)
MX (1) MXPA99011001A (hu)
NO (1) NO995842L (hu)
NZ (1) NZ500531A (hu)
PL (1) PL337066A1 (hu)
PT (1) PT984975E (hu)
SI (1) SI0984975T1 (hu)
SK (1) SK160299A3 (hu)
TR (1) TR199902820T2 (hu)
WO (1) WO1998054197A1 (hu)
ZA (1) ZA984488B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003501439A (ja) * 1999-06-07 2003-01-14 アボット・ラボラトリーズ 6−o−カルバメートケトライド誘導体
WO2006074962A2 (en) * 2005-01-12 2006-07-20 Alpharma Aps Erythromycin derivatives as antibacterial agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2096915T3 (es) * 1992-04-22 1997-03-16 Taisho Pharmaceutical Co Ltd Derivado de 5-o-desosaminileritronolida a.
DE69631609T2 (de) * 1995-11-08 2005-01-05 Abbott Laboratories, Abbott Park Tricyclische erythromycinderivate

Also Published As

Publication number Publication date
AU7591298A (en) 1998-12-30
NO995842D0 (no) 1999-11-29
ES2197472T3 (es) 2004-01-01
JP2002500669A (ja) 2002-01-08
HUP0004809A2 (hu) 2001-05-28
IL132482A0 (en) 2001-03-19
KR20010013041A (ko) 2001-02-26
MXPA99011001A (es) 2003-09-10
DE69813798T2 (de) 2004-02-19
CA2290421A1 (en) 1998-12-03
DE69813798D1 (en) 2003-05-28
EP0984975A1 (en) 2000-03-15
SK160299A3 (en) 2000-06-12
CA2290421C (en) 2007-05-08
NO995842L (no) 2000-01-26
DK0984975T3 (da) 2003-08-11
JP4368950B2 (ja) 2009-11-18
CO4950620A1 (es) 2000-09-01
EP0984975B1 (en) 2003-04-23
PL337066A1 (en) 2000-07-31
CN1258299A (zh) 2000-06-28
ZA984488B (en) 1998-12-02
AR013081A1 (es) 2000-12-13
NZ500531A (en) 2001-07-27
SI0984975T1 (en) 2004-02-29
ATE238330T1 (de) 2003-05-15
BG103985A (en) 2000-07-31
WO1998054197A1 (en) 1998-12-03
PT984975E (pt) 2003-09-30
BR9809489A (pt) 2000-06-20
TR199902820T2 (xx) 2000-04-21

Similar Documents

Publication Publication Date Title
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
HUP0001518A3 (en) Tricyclic erythromycin derivatives
IL137024A0 (en) Novel macrolides
GB9702194D0 (en) Sulphonide derivatives
PL348333A1 (en) Macrolides
AU9277698A (en) 9-amino-3-keto erythromycin derivatives
AP9801421A0 (en) Novel erythromycin derivatives
IL132767A0 (en) 9-Oxime erythromycin derivatives
IL135519A0 (en) 2-halo-6-0-substituted ketolide derivatives
IL134220A0 (en) 6,9-bridged erythromycin derivatives
IL134996A0 (en) 6,11-bridged erythromycin derivatives
ZA989835B (en) Erythromycin a derivatives
ZA989830B (en) Erythromycin a derivatives
AU8925398A (en) 3-descladinose 6-o-substituded erythromycin derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
ZA981572B (en) Erythromycin a derivatives
AU6932098A (en) Erythromycin derivatives
EP1044985A4 (en) ERYTHROMYCIN DERIVATIVES
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
GB9701427D0 (en) Gemcitabine derivatives
HUP0004809A3 (en) Multicyclic erythromycin derivatives
GB9700702D0 (en) Erythromycin derivatives
ZA989845B (en) 2-halo-6-O-substituted ketolide derivatives
SI1027362T1 (sl) 2-halo-6-O-substituirani derivati ketolidov